المؤلفون: Mònica Sabaté, Francesco Rossi, Corinne Zara, Pili Ferrer, Elena Ballarín, Anna Coma, Annalisa Capuano, Luisa Ibáñez, Joan-Ramon Laporte, Concita Rafaniello

المساهمون: Rafaniello, Concetta, Rossi, Francesco, Capuano, Annalisa, The research leading to these results was conducted as part of the PROTECT Consortium (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium, www.imi-protect.eu) which is a public-private partnership coordinated by the Euro

المصدر: Epidemiology, Biostatistics, and Public Health; V. 11 N. 3 (2014)
Epidemiology, Biostatistics, and Public Health; Vol. 11 No. 3 (2014)
Epidemiology Biostatistics and Public Health, Vol 11, Iss 3 (2014)
Epidemiology, Biostatistics and Public Health; Vol 11, No 3 (2014)

مصطلحات موضوعية: Topiramate, Pediatrics, medicine.medical_specialty, Epidemiology, Population, Pregabalin, Cross-national comparison, Norwegian, Cross-national comparison, drug utilisation, antiepileptic drugs, DID, Danish, 03 medical and health sciences, 0302 clinical medicine, Health care, Medicine, Drug utilisation, 030212 general & internal medicine, Defined daily doses/1,000 inhabitants/day, Medical prescription, education, Community and Home Care, education.field_of_study, lcsh:R5-920, business.industry, lcsh:Public aspects of medicine, Health Policy, Public Health, Environmental and Occupational Health, lcsh:RA1-1270, language.human_language, language, Levetiracetam, business, lcsh:Medicine (General), 030217 neurology & neurosurgery, Antiepileptic drug, medicine.drug, Demography

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff57edb29c2c26b2e30e14b712292c2e
http://hdl.handle.net/11591/361736